Medical Enzymes and Nektar Therapeutics announce PEGylation cooperation
26-Sep-2006
Under the terms of the agreement, Nektar will provide Medical Enzymes with its Advanced PEGylation technology for use in GlutaDON® and Medical Enzymes will pay Nektar an upfront fee, milestone payments, manufacturing revenues, and royalties on product sales.
Most read news
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.